European Journal of Dermatology
MENUD-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review Volume 28, issue 6, November-December 2018
Tables
2 University of Copenhagen,
Center for Medical Research Methodology,
Department of Biomedical Sciences,
Copenhagen,
Denmark
Center for Medical Research Methodology,
Department of Biomedical Sciences,
Copenhagen,
Denmark
* Reprints
- Key words: chronic urticaria, d-dimer, biomarker, disease activity, treatment response
- DOI : 10.1684/ejd.2018.3443
- Page(s) : 731-5
- Published in: 2018
Chronic urticaria is an itchy skin disease, which is treated with antihistamines; however, a large group of patients are unresponsive to antihistamines alone and are thus treated with omalizumab, although a small fraction of these patients have particularly recalcitrant disease. Currently, there are no reliable biomarkers available to assess disease activity/severity and treatment response in chronic urticaria patients. However, it has been reported that high levels of